Original Research

Results of a Time and Motion Survey Regarding Subcutaneous versus Intravenous Administration of Daratumumab in Patients with Relapsed or Refractory Multiple Myeloma

Slavcev M, Spinelli A, Absalon E, Masterson T, Heuck C, Lam A, De Cock E

ClinicoEconomics and Outcomes Research 2021, 13:465-473

Published Date: 8 June 2021